Does HLA matching matter in the modern era of renal transplantation?

Deceased donors Human leukocyte antigens Kidney transplantation Living donors Matching Mismatching

Journal

Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728

Informations de publication

Date de publication:
01 2021
Historique:
received: 19 02 2019
accepted: 06 09 2019
revised: 02 07 2019
pubmed: 11 12 2019
medline: 15 12 2021
entrez: 11 12 2019
Statut: ppublish

Résumé

Children with end-stage kidney disease should be offered the best chance for future survival which ideally would be a well-matched pre-emptive kidney transplant. Paediatric and adult practice varies around the world depending on geography, transplant allocation schemes and different emphases on living (versus deceased) donor renal transplantation. Internationally, paediatric patients often have priority in allocation schemes and younger donors are preferentially allocated to paediatric recipients. HLA matching can be difficult and may result in longer waiting times. Additionally, with improved surgical techniques and modern immunosuppressive regimens, how important is the contribution of HLA matching to graft longevity? In this review, we discuss the relative importance of HLA matching compared with donor quality; and long-term patient outcomes including re-transplantation rates. We share empirical evidence that will be useful for clinicians and families to make decisions about best donor options. We discuss why living donation still provides the best allograft survival outcomes and what to do in the scenario of a highly mismatched living donor.

Identifiants

pubmed: 31820146
doi: 10.1007/s00467-019-04393-6
pii: 10.1007/s00467-019-04393-6
pmc: PMC7701071
doi:

Substances chimiques

HLA Antigens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

31-40

Subventions

Organisme : Department of Health
Pays : United Kingdom

Références

Am J Transplant. 2016 May;16(5):1367-70
pubmed: 26833680
Anesth Analg. 2015 Jan;120(1):239-45
pubmed: 25625266
Kidney Int. 2016 Nov;90(5):1100-1108
pubmed: 27653837
Pediatr Nephrol. 2005 Nov;20(11):1636-41
pubmed: 16133057
Clin J Am Soc Nephrol. 2018 May 7;13(5):763-771
pubmed: 29685925
Transplantation. 2009 Jul 15;88(1):23-9
pubmed: 19584676
Hum Immunol. 2007 Jan;68(1):12-25
pubmed: 17207708
BMJ Open. 2017 Aug 18;7(8):e015867
pubmed: 28821519
Am J Transplant. 2008 Oct;8(10):2056-61
pubmed: 18839440
Front Immunol. 2016 Dec 07;7:575
pubmed: 28003816
Curr Opin Organ Transplant. 2018 Aug;23(4):477-485
pubmed: 29870434
Nature. 1983 Oct 20-26;305(5936):726-9
pubmed: 6415484
Nephrol Dial Transplant. 2013 Jan;28(1):9-11
pubmed: 22987141
Transpl Int. 2013 Feb;26(2):e8-9
pubmed: 23230987
Hum Immunol. 2011 Nov;72(11):1049-59
pubmed: 21840357
Transplantation. 2010 Aug 15;90(3):292-7
pubmed: 20548266
Curr Opin Organ Transplant. 2016 Aug;21(4):441-6
pubmed: 27200497
Nephrol Dial Transplant. 2017 Nov 1;32(11):1949-1956
pubmed: 28992338
Pediatr Transplant. 2018 Nov;22(7):e13265
pubmed: 29992708
N Engl J Med. 1969 Apr 3;280(14):735-9
pubmed: 4886455
Am J Transplant. 2014 Oct;14(10):2350-8
pubmed: 25167892
J Immunol. 2013 Dec 15;191(12):5785-91
pubmed: 24319282
Transpl Int. 2016 Apr;29(4):403-15
pubmed: 26756928
Hum Immunol. 2000 Mar;61(3):185-9
pubmed: 10689107
Am J Transplant. 2013 Aug;13(8):2066-74
pubmed: 23718940
Transplantation. 2013 Sep 15;96(5):469-75
pubmed: 23759881
Transpl Int. 2012 May;25(5):545-54
pubmed: 22353435
Transplantation. 1987 Aug;44(2):214-20
pubmed: 3307044
Pediatr Nephrol. 2012 Mar;27(3):363-73
pubmed: 21713524
Transplantation. 1986 Aug;42(2):144-50
pubmed: 3526654
Transplant Direct. 2018 Jun 13;4(7):e365
pubmed: 30046655
Am J Transplant. 2017 Jan;17 Suppl 1:543-564
pubmed: 28052605
Transpl Int. 2019 Jul;32(7):751-761
pubmed: 30801866
Pediatr Transplant. 2001 Feb;5(1):5-15
pubmed: 11260482
Transplantation. 2017 Nov;101(11):2789-2792
pubmed: 28471872
Transplantation. 2016 Dec;100(12):2717-2722
pubmed: 26985746
Transplantation. 2013 May 27;95(10):1218-24
pubmed: 23478360
Am J Transplant. 2012 Dec;12(12):3289-95
pubmed: 22947033
Adv Chronic Kidney Dis. 2016 Sep;23(5):281-286
pubmed: 27742381
Transplantation. 2018 Aug;102(8):1338-1343
pubmed: 29443827
Transplantation. 1996 Mar 15;61(5):709-14
pubmed: 8607172
Clin J Am Soc Nephrol. 2016 May 6;11(5):875-83
pubmed: 27034399
Transplantation. 2011 Jan 27;91(2):183-90
pubmed: 21079553
Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2198-204
pubmed: 26430089
Clinics (Sao Paulo). 2014;69 Suppl 1:28-38
pubmed: 24860856
World J Transplant. 2018 Jun 28;8(3):52-60
pubmed: 29988896
J Am Soc Nephrol. 2014 Aug;25(8):1842-8
pubmed: 24833128
Am J Transplant. 2017 Mar;17(3):692-702
pubmed: 27501275
J Am Soc Nephrol. 2017 Nov;28(11):3353-3362
pubmed: 28729289
Am J Transplant. 2017 Oct;17(10):2650-2658
pubmed: 28371054
J Am Soc Nephrol. 2016 Sep;27(9):2833-41
pubmed: 26888475
Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1148-1160
pubmed: 28596416
Am J Transplant. 2014 Apr;14(4):876-85
pubmed: 24612783

Auteurs

Jon Jin Kim (JJ)

Department of Paediatric Nephrology, Nottingham Children's Hospital, Nottingham, NG7 2UH, UK.
Institute of Medical Sciences, Faculty of Medicine, University of Liverpool, Liverpool, L69 3BX, UK.

Susan V Fuggle (SV)

NHS Blood and Transplant, Bristol, BS34 8RR, UK.
Oxford Transplant Centre, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, OX3 7LE, UK.

Stephen D Marks (SD)

Department of Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK. Stephen.Marks@gosh.nhs.uk.
NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London Great Ormond Street Institute of Child Health, London, WC1N 1EH, UK. Stephen.Marks@gosh.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH